Cigna Corporation
Bear Case (25th pct.)
60.4% vs price
Base Case (Median)
95.3% vs price
Bull Case (75th pct.)
214.6% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $1047.08 | 280.3% | High (40%) |
| PE Comparable | $537.66 | 95.3% | Medium (25%) |
| Growth Trajectory DCF | $1199.06 | 335.5% | Medium (20%) |
| Graham Number | $292.00 | 6.1% | Medium (40%) |
| EV/EBITDA | $436.44 | 58.5% | Medium (20%) |
| EV/FCF | $685.32 | 148.9% | Medium (20%) |
| Earnings Power Value | $446.75 | 62.3% | Medium (50%) |
Based on 7 out of 8 methods, CI appears undervalued at the current price of $275.33. The base case fair value of $537.66 implies 95.3% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.